Filtered By:
Management: Medicaid
This page shows you your search results in order of relevance. This is page number 11.
Order by Relevance | Date
Total 217 results found since Jan 2013.
Industry relationships are associated with performing a greater number of sinus balloon dilation procedures
ConclusionThere is an association between receiving money from industry and the frequency with which otolaryngologists employ BD. Although our analysis demonstrates an association, these results in no way imply causation. Further analysis exploring the reasons for this association may be necessary.
Source: International Forum of Allergy and Rhinology - June 1, 2017 Category: Allergy & Immunology Authors: Jean Anderson Eloy, Peter F. Svider, Michael Bobian, Richard J. Harvey, Stacey T. Gray, Soly Baredes, Adam J. Folbe Tags: ORIGINAL ARTICLE Source Type: research
Medicaid Enrollees Are Satisfied With Their Health Care
Enrollees rate their overall health care at 7.9, on average, on a scale of 1 to 10
Source: The Doctors Lounge - Psychiatry - July 12, 2017 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news
Emergency department use for acute rhinosinusitis: Insurance dependent for children and adults
ConclusionWith respect to absolute numbers of visits, patients with Medicaid or no insurance use less care overall for uncomplicated ARS than do privately insured patients. Medicaid is associated with ED presentation for ARS for pediatric and adult visits. Self‐pay insurance status is strongly associated with ED presentation for adult and pediatric visits, and is significantly more common for children. These results suggest limitations in primary care access for uncomplicated ARS based on insurance status, particularly for uninsured pediatric patients.
Level of Evidence4. Laryngoscope, 2017
Source: The Laryngoscope - July 21, 2017 Category: ENT & OMF Authors: Regan W. Bergmark, Stacey L. Ishman, Katie M. Phillips, Michael J. Cunningham, Ahmad R. Sedaghat Tags: Allergy/Rhinology Source Type: research
Disparities in sinonasal squamous cell carcinoma short ‐ and long‐term outcomes: Analysis from the national cancer database
ConclusionsSociodemographic and economic differences in outcomes of patients with sinonasal SCC cancer exist. An understanding of these differences may help minimize disparities in oncologic treatment.
Level of Evidence2c. Laryngoscope, 2017
Source: The Laryngoscope - August 16, 2017 Category: ENT & OMF Authors: Ryan M. Carey, Arjun K. Parasher, Alan D. Workman, Carol H. Yan, Jordan T. Glicksman, Jinbo Chen, James N. Palmer, Nithin D. Adappa, Jason G. Newman, Jason A Brant Tags: Allergy/Rhinology Source Type: research
EpiPen maker settles federal claims for $465M a year after Sanofi filed suit
Mylan NV will pay $465 million fine to settle claims brought by the U.S. Justice Department that it overcharged the government for its emergency allergy drug, EpiPen.
The U.S. Attorney’s Office in Massachusetts announced the agreement on Thursday, saying it had violated the False Claims Act “by knowingly misclassifying EpiPen, a branded epinephrine auto-injector drug, as a generic drug to avoid paying rebates owed to Medicaid.”
French drug company Sanofi , the parent company of the state’s…
Source: bizjournals.com Health Care:Physician Practices headlines - August 17, 2017 Category: American Health Authors: Don Seiffert Source Type: news
Mylan inks $465m settlement with DOJ over EpiPen Medicaid classification
Mylan (NSDQ:MYL) said today that it inked a $465 million deal with U.S. Dept. of Justice to settle claims that it misclassified its EpiPen allergy auto-injector device with the Medicaid Drug Rebate Program.
In October last year, The Centers for Medicare & Medicaid Services said that Mylan had been overcharging Medicaid for its EpiPen device for years, despite being warned that it should have paid bigger rebates.
Get the full story at our sister site, Drug Delivery Business News.
The post Mylan inks $465m settlement with DOJ over EpiPen Medicaid classification appeared first on MassDevice.
Source: Mass Device - August 17, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Drug-Device Combinations Legal News Pharmaceuticals Wall Street Beat Centers for Medicare and Medicaid Services (CMS) Mylan Source Type: news
Pa. to get $8.3M in Mylan EpiPen settlement
Pennsylvania will receive $8.3 million from the settlement between Mylan NV and the U.S. Department of Justice over EpiPen pricing.
The settlement, announced Thursday, involves the federal government's claims that it was overcharged for the anti-allergy treatment under Medicaid programs. Mylan did not acknowledge wrongdoing but agreed to the $456 million settlement.
"As we said when we announced the settlement last year, brin ging closure to this matter is the right course of action for Mylan and…
Source: bizjournals.com Health Care News Headlines - August 18, 2017 Category: Health Management Authors: Paul J. Gough Source Type: news
Colorado Medicaid will get $5.5 million of EpiPen settlement
Colorado ’s Medicaid program will get a piece of the $465 million U.S. Justice Department settlement with the makers of the EpiPen.
The settlement follows a lawsuit accusing the pharmaceutical company of overcharging the government’s Medicaid program for the EpiPens, a hand-held device used for emergenc y allergy treatments.
Colorado will receive $5.5 million of that settlement with Mylan Inc. and Mylan Specialty L.P. – the companies accused of knowingly underpaying rebates owed to the Medicaid…
Source: bizjournals.com Health Care:Biotechnology headlines - August 29, 2017 Category: Biotechnology Authors: Monica Mendoza Source Type: news
Decomposition Analysis of Black –White Disparities in Birth Outcomes: The Relative Contribution of Air Pollution and Social Factors in California
Conclusions:
Our results suggest that, although the role of individual and neighborhood factors remains prevailing in explaining black–white differences in birth outcomes, the individual contribution of PM2.5 is comparable in magnitude to any single individual- or neighborhood-level factor. https://doi.org/10.1289/EHP490
Received: 10 May 2016
Revised: 16 December 2016
Accepted: 03 January 2017
Published: 04 October 2017
Address correspondence to T. Benmarhnia, Department of Family Medicine and Public Health, and Scripps Institution of Oceanography, University of California, San Diego, 9500 Gilman Drive, La Jolla, C...
Source: EHP Research - October 4, 2017 Category: Environmental Health Authors: Daniil Lyalko Tags: Research Source Type: research
Association of prenatal folate status with early childhood wheeze and atopic dermatitis
ConclusionsHigh plasma folate in mid‐pregnancy was associated with decreased odds of current wheeze at age 3. Our findings do not support harmful effects of high prenatal folate levels on childhood atopic diseases in this setting.This article is protected by copyright. All rights reserved.
Source: Pediatric Allergy and Immunology - November 23, 2017 Category: Allergy & Immunology Authors: Aditi Roy, Mehmet Kocak, Terryl J. Hartman, Shanda Vereen, Margaret Adgent, Chandrika Piyathilake, Frances A. Tylavsky, Kecia N. Carroll Tags: Original Source Type: research
Children Covered by Medicaid/State Children's Health Insurance Program More Likely to Use Emergency Departments for Food Allergies
This study identified trends and factors related to ED visits for pediatric FAs in the United States from 2001 to 2010. It was hypothesized that FAs increased and that differences existed in ED utilization based on age, insurance status, and geography. Low concordance with treatment guidelines for FAs was expected.
Methods
Multivariate logistic regression, using National Hospital Ambulatory Medical Care Survey data, estimated factors associated with ED visits and treatment of FAs and nonspecific allergic reactions. Trends and treatment patters used weighted frequencies to account for the complex 4-stage probability surv...
Source: Pediatric Emergency Care - December 1, 2017 Category: Emergency Medicine Tags: Original Articles Source Type: research
Deceleration in Health Care Spending Growth in 2016
Enrollment trends drove slowdown in Medicaid and private health insurance spending growth in 2016
Source: The Doctors Lounge - Psychiatry - December 11, 2017 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news
Medicaid Expansion Cuts Out - of - Pocket Spending
Study finds expansion also improved insurance status relative to non - expansion states
Source: The Doctors Lounge - Psychiatry - November 11, 2014 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news
